待处理
入排:排除
图源:待检查
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors.
S V Liu, R Dziadziuszko, S Viteri, F Cappuzzo, S Comis, V Gabarre, C Chevalier, T Vandewalle, F Montestruc, B Vasseur, J Remon, B Besse
Lung Cancer 203 108516
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板